Theraclion Strengthens Its Management Team By Appointing David Caumartin As Theraclion's CEO, And Anja Kleber As Vice-President Marketing/Market Access
Malakoff - France, 2 September 2014 - THERACLION (Alternext, FR0010120402 - ALTHE, eligible for the PEA PME), a company specializing in cutting edge medical equipment for echotherapy, announced today that it has strengthened its management team by appointing David Caumartin to succeed Stefano Vagliani as Theraclion's CEO, and Anja Kleber as Vice-President Marketing/Market Access.
David Caumartin is healthcare industry specialist with 14 years' experience at GE Healthcare, covering Europe, Middle East and Africa and the USA working in sales, marketing and development of new products, scanners and conventional radiology. From 2007 to 2011 he was global head of mammography. In 2012, David joined Alstom Thermal Power as VP responsible for M&A strategy. He is a graduate of Telecom Paris with a masters in fundamental physics from Paris Diderot University and is also a certified Six Sigma Master Black Belt.
Anja Kleber began her career in 2002 in the Siemens Medical marketing team. In 2006, she joined Accuray as Head of Radiosurgery/Radiotherapy products. She was promoted to "Head of Public Affairs" in 2009 before being appointed Head of Marketing/Market Access a year later. She made a big contribution to the development of Accuray which is now one of the leading players in the market. Anja is an IT graduate of the University of Karlsruhe and did her thesis at INSA Lyon. She has dual French-German nationality.
"On behalf of all our teams, I would like to thank Stefano Vagliani for the direction he gave Theraclion during his time as CEO, and particularly for his contribution to setting up the company's organization and procedures and his work during the flotation. The appointment of this new management team is a major step for Theraclion. The arrival of these new top-tier managers will allow us to drive forward the company's commercial development and consolidate our presence in our target markets" said Jean-Yves Burel, Chairman of the Board of Directors
About Theraclion
Based in Malakoff, near Paris, Theraclion is a French company specialized in cutting-edge medical devices for echotherapy. Theraclion designs, develops and markets a medical device (Echopulse®) that combines advanced ultrasound imaging and HIFU therapy. Theraclion is ISO 13485 certified and has received the CE mark for non-invasive ablation of breast fibroadenomas and thyroid nodules. A full 70% of its 19-strong team are dedicated to R&D and clinical trials. For more information, visit http://www.theraclion.com.
Theraclion is listed on Alternext Paris
PEA-PME Eligible
Mnemonic: ALTHE - ISIN Code: FR0010120402
Contacts:
Theraclion
Sarah Ankri
CFO
Tel.: +33 (0)1 55 48 90 70
sarah.ankri@theraclion.com
NewCap.
Financial Communications & Investors relations
Emmanuel Huynh / Sophie Boulila
Tel.: +33 (0)1 44 71 94 91
theraclion@newcap.fr
ALIZE RP
Press Relations
Caroline Carmagnol / Valentine Boivin
Tel.: + 33 (0)1 70 22 53 92
theraclion@alizerp.com
Help employers find you! Check out all the jobs and post your resume.